|
UA67721C2
|
|
Modified release pharmaceutical composition and method for treatment of inflammatory bowel diseases
|
|
US6004581A
|
|
Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
|
|
US5629012A
|
|
Process for producing suppositories by compression and suppositories obtained by the process
|
|
US5716648A
|
|
Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel diseases
|
|
DK116591D0
|
|
Procedure for the preparation of suppositories by compression and suppositions obtained by the procedure
|
|
US4960765A
|
|
Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
|
|
DK536987D0
|
|
Application of 5-aminosalicylic acid (5-asa) for the preparation of a pharmaceutical preparation for use in reperfusion treatment
|
|
DK378887D0
|
|
Use of 5-aminosalicylic acid (5-asa) for the preparation of a pharmaceutical preparation for the treatment of cataracter
|
|
DK197486D0
|
|
5-fluoruracilprodug
|
|
US4670112A
|
|
Process for preparing p-amino phenols by electrolysis
|
|
US4664256A
|
|
Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
|
|
CA1230056A
|
|
Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
|
|
CA1222459A
|
|
Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
|
|
WO8102671A1
|
|
Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
|
|
WO8102672A1
|
|
Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease
|
